<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>JS-2 is a novel gene located at 5p15.2 and originally detected in primary <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>There is no study on the role of JS-2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study is to determine the gene copy number and expression of JS-2 in a large cohort of patients with <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumours</z:e> and correlate these to the clinicopathological features of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>We evaluated the DNA copy number and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of JS-2 in 176 colorectal tissues (116 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, 30 <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 30 non-neoplastic tissues) using real-time polymerase chain reaction </plain></SENT>
<SENT sid="4" pm="."><plain>JS-2 expression was also evaluated in two <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines and a benign colorectal cell line </plain></SENT>
<SENT sid="5" pm="."><plain>JS-2 amplification was noted in 35% of the colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Significant differences in relative expression levels for JS-2 mRNA between different colorectal tissues were noted (p = 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Distal colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> had significantly higher copy number than proximal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (p = 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>The relative expression level of JS-2 was different between colonic and <z:mp ids='MP_0009315'>rectal adenocarcinoma</z:mp> (p = 0.007) </plain></SENT>
<SENT sid="9" pm="."><plain>Mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> showed higher JS-2 expression than non-mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (p = 0.02) </plain></SENT>
<SENT sid="10" pm="."><plain>Early T-stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> appear to have higher JS-2 copy number and lower expression of JS-2 mRNA than later stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (p = 0.001 and 0.03 respectively) </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> cell lines showed lower expression of JS-2 than the benign colorectal cell line </plain></SENT>
<SENT sid="12" pm="."><plain>JS-2 copy number change and expression were shown for the first time to be altered in the <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>In addition, genetic alteration of JS-2 was found to be related to location, pathological subtypes and staging of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>